PGF and preeclampsia: These associations support the clinical use of the maternal serum sFLT1:PlGF ratio (or PlGF on its own) to rule in or rule out preeclampsia in women presenting with features suggestive of the disease,1 and this has been included in clinical guidelines in the United Kingdom and other European countries.2